Statera Biopharma, Inc. (STAB)
OTCMKTS: STAB · Delayed Price · USD
0.0003
-0.0003 (-50.00%)
Feb 22, 2024, 10:30 AM EDT - Market closed
Statera Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.84 | 0.59 | 0 | 3.62 | 4.23 | 6.9 | 5.92 | 1,473 | 10,048 | 25,652 | Upgrade
|
Short-Term Investments | 0.13 | 0.32 | 0.45 | 0.5 | 4.56 | 8.34 | 13.7 | 2,198 | 305.54 | 2,634 | Upgrade
|
Cash & Cash Equivalents | 1.98 | 0.59 | 0 | 4.12 | 8.79 | 15.25 | 19.62 | 3,671 | 10,354 | 28,286 | Upgrade
|
Cash Growth | 233.29% | 35892.06% | -99.96% | -53.13% | -42.33% | -22.30% | -99.47% | -64.54% | -63.40% | 99523.24% | Upgrade
|
Receivables | 0.35 | 0.01 | 0.38 | 0.25 | 0.55 | 0.35 | 0.63 | -416.5 | 458.39 | 41.9 | Upgrade
|
Inventory | 1.81 | -0.01 | -0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 0.02 | 0.01 | -0.41 | 0.1 | 0.23 | 0.29 | 0.44 | 0 | 344.39 | 1,078 | Upgrade
|
Total Current Assets | 4.16 | 0.93 | 0 | 4.48 | 9.58 | 15.89 | 20.69 | 3,255 | 11,157 | 29,406 | Upgrade
|
Property, Plant & Equipment | 1.17 | 0.11 | 0 | 0 | 0 | 0 | 0 | 293.16 | 0 | 0 | Upgrade
|
Goodwill | 9.27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Intangible Assets | 1.58 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 5 | 0 | 0.03 | 0.06 | 0.05 | 0.07 | 0.19 | 0 | 3,539 | 2,604 | Upgrade
|
Total Long-Term Assets | 17.01 | 0.11 | 0.03 | 0.06 | 0.05 | 0.07 | 0.19 | 293.16 | 3,539 | 2,604 | Upgrade
|
Total Assets | 21.17 | 1.04 | 0 | 4.53 | 9.63 | 15.96 | 20.88 | 3,548 | 14,696 | 32,010 | Upgrade
|
Accounts Payable | 3.96 | 2.69 | 2.41 | 0.14 | 0.2 | 0.34 | 0.2 | -713.5 | 794.4 | 1,524 | Upgrade
|
Deferred Revenue | 0.37 | -0.14 | -1.26 | 0 | 0 | 0 | 0.01 | -2,062.33 | 1,069 | 3,315 | Upgrade
|
Current Debt | 4.83 | 1.93 | 1.8 | 0 | 0 | 0 | 0 | 0 | 83.63 | 71.68 | Upgrade
|
Other Current Liabilities | 2.08 | 0.14 | 1.26 | 0.77 | 2.01 | 2.77 | 5.63 | 0 | 4,038 | 6,516 | Upgrade
|
Total Current Liabilities | 11.25 | 4.62 | 4.21 | 0.91 | 2.21 | 3.11 | 5.84 | -2,775.83 | 5,986 | 11,427 | Upgrade
|
Long-Term Debt | 11.43 | 0.07 | 0 | 0 | 0 | 0 | 0 | 7,328 | 7,129 | 97.6 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Liabilities | 11.43 | 0.07 | 0 | 0.01 | 0.01 | 0 | 0 | 7,328 | 7,129 | 97.6 | Upgrade
|
Total Liabilities | 22.68 | 4.69 | 4.21 | 0.92 | 2.22 | 3.11 | 5.84 | 4,552 | 13,115 | 11,524 | Upgrade
|
Total Debt | 16.26 | 2 | 1.8 | 0 | 0 | 0 | 0 | 7,328 | 7,213 | 169.28 | Upgrade
|
Debt Growth | 711.69% | 11.02% | - | - | - | - | - | 1.60% | 4160.69% | - | Upgrade
|
Common Stock | 0.18 | 0.02 | 0.02 | 0.06 | 0.06 | 0.05 | 0.05 | 0 | 225.91 | 223.65 | Upgrade
|
Retained Earnings | -129.48 | -27.63 | -15.54 | -164.06 | -160.45 | -150.74 | -147.98 | 0 | -135,564.67 | -118,301.79 | Upgrade
|
Comprehensive Income | -0.01 | -0.69 | -0.57 | -0.61 | 0 | 0 | 0 | 0 | 307.34 | 546.47 | Upgrade
|
Shareholders' Equity | -1.57 | -3.66 | -4.21 | -1.45 | 2.2 | 7.52 | 9.89 | -1,003.79 | -9,522.95 | 6,333 | Upgrade
|
Total Liabilities and Equity | 21.17 | 1.04 | 0 | 4.53 | 9.63 | 15.96 | 20.88 | 3,548 | 14,696 | 32,010 | Upgrade
|
Net Cash / Debt | -14.28 | -1.08 | -1.35 | 4.12 | 8.79 | 15.25 | 19.62 | -3,656.29 | 3,141 | 28,117 | Upgrade
|
Net Cash / Debt Growth | - | - | - | -53.13% | -42.33% | -22.30% | - | - | -88.83% | 98927.03% | Upgrade
|
Net Cash Per Share | -0.41 | -0.04 | -0.05 | 0.36 | 0.79 | 1.39 | 2.78 | -1.35 | 0.07 | 0.75 | Upgrade
|
Working Capital | -7.09 | -3.7 | -4.21 | 3.56 | 7.37 | 12.78 | 14.85 | 6,031 | 5,171 | 17,979 | Upgrade
|
Book Value Per Share | -0.04 | -0.14 | -0.16 | -0.13 | 0.20 | 0.68 | 1.40 | -0.37 | -0.21 | 0.17 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.